| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TTC39C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ULBP3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | SLC52A3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | RNF24 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | TBCA | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | ZCRB1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | RP11-5A19.5 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | TBC1D30 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | RP11-435I10.4 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
